Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma

Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma

Cantharidin (CTD) is the major component of anticancer drugs obtained from <i>Mylabris Cichorii</i> and has a good inhibitory effect on several cancers, including hepatocellular carcinoma (HCC) and breast cancer. However, due to its toxicity, oral administration can cause various adverse...

Full description

Bibliographic Details
Main Authors: Yilin Xu, Min Wang, Shuangcheng Ning, Zhonglan Yang, Lili Zhou, Xinhua Xia
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Molecules
Subjects:
cantharidin
solid lipid nanoparticles
glycyrrhetinic acid
folate
antitumor
liver-targeting
Online Access:https://www.mdpi.com/1420-3049/27/20/6786

Internet

https://www.mdpi.com/1420-3049/27/20/6786

Similar Items